Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States

被引:4
作者
Gormley, Mirinda Ann [1 ]
Blondino, Courtney T. [1 ]
Taylor, DaShaunda D. H. [1 ,2 ]
Lowery, Elizabeth [1 ]
Clifford, James S. [1 ]
Burkart, Benjamin [1 ]
Graves, Whitney C. [1 ]
Prom-Wormley, Elizabeth C. [1 ]
Lu, Juan [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Div Epidemiol, POB 980212, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Ctr Soc & Hlth, Richmond, VA 23298 USA
关键词
analgesics; opioids; patient compliance; patient dropout; substance abuse detection; treatment outcome; METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; INJECTION-DRUG USERS; CONTINGENCY MANAGEMENT; TREATMENT RETENTION; TREATMENT OUTCOMES; BUPRENORPHINE TREATMENT; DEPENDENT PATIENTS; OPIOID DEPENDENCE; CLINICAL-TRIALS;
D O I
10.1093/epirev/mxaa009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The effectiveness of opiate treatment programs (OTPs) can be significantly influenced by co-occurring substance use, yet there are no standardized guidelines for assessing the influence of co-occurring substance use on treatment outcomes. In this review, we aim to provide an overview on the status of the assessment of co-occurring substance use during participation in OTPs in the United States. We searched 4 databases-MEDLINE/PubMed, EMBASE, PsychINFO, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL)-from database inception to November 2018 to select relevant publications on OTPs that assessed participants' co-occurring substance use. We used a standardized protocol to extract study, intervention, and co-occurring substance use characteristics. Methodological quality was assessed using the Quality in Prognosis Studies tool. Of the 3,219 titles screened, 614 abstracts and 191 full-text original publications were assessed, leaving 85 eligible articles. Co-occurring substance use was most often assessed during opioid treatments using combined (pharmacological and behavioral) (n = 57 studies) and pharmacological (n = 25 studies) interventions. Cocaine, alcohol, marijuana, and benzodiazepines were frequently measured, while amphetamines and tobacco were rarely assessed. Great variation existed between studies in the timing and measurement of co-occurring substance use, as well as definitions for substances and polysubstance/polydrug use. Inconsistencies in the investigation of co-occurring substance use make comparison of results across studies challenging. Standardized measures and consensus on research on co-occurring substance use is needed to produce the evidence required to develop personalized treatment programs for persons using multiple substances and to inform best-practice guidelines for addressing polydrug use during participation in OTPs.
引用
收藏
页码:79 / 102
页数:24
相关论文
共 111 条
[41]   Response to methadone maintenance treatment of opiate dependent patients with and without significant pain [J].
Ilgen, MA ;
Trafton, JA ;
Humphreys, K .
DRUG AND ALCOHOL DEPENDENCE, 2006, 82 (03) :187-193
[42]   Glucocorticoids and cognitive function: from physiology to pathophysiology [J].
Jameison, K ;
Dinan, TG .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (04) :293-302
[43]  
Joe GW, 1998, ADDICTION, V93, P1177
[44]   Co-occurring substance use and mental disorders among adults with opioid use disorder [J].
Jones, Christopher M. ;
McCance-Katz, Elinore F. .
DRUG AND ALCOHOL DEPENDENCE, 2019, 197 :78-82
[45]   Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers [J].
Jones, HE ;
Wong, CJ ;
Tuten, M ;
Stitzer, ML .
DRUG AND ALCOHOL DEPENDENCE, 2005, 79 (02) :119-128
[46]   Polydrug abuse: A review of opioid and benzodiazepine combination use [J].
Jones, Jermaine D. ;
Mogali, Shanthi ;
Comer, Sandra D. .
DRUG AND ALCOHOL DEPENDENCE, 2012, 125 (1-2) :8-18
[47]   Co-morbidity of smoking in patients with psychiatric and substance use disorders [J].
Kalman, D ;
Morissette, SB ;
George, TP .
AMERICAN JOURNAL ON ADDICTIONS, 2005, 14 (02) :106-123
[48]   Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances [J].
Kandel, Denise B. ;
Hu, Mei-Chen ;
Griesler, Pamela ;
Wall, Melanie .
DRUG AND ALCOHOL DEPENDENCE, 2017, 178 :501-511
[49]   Improvements in Outcomes in Methadone Patients on Probation/Parole Regardless of Counseling Early in Treatment [J].
Kelly, Sharon M. ;
O'Grady, Kevin E. ;
Jaffe, Jerome H. ;
Gandhi, Devang ;
Schwartz, Robert P. .
JOURNAL OF ADDICTION MEDICINE, 2013, 7 (02) :133-138
[50]   A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management [J].
Kennedy, Ashley P. ;
Phillips, Karran A. ;
Epstein, David H. ;
Reamer, David A. ;
Schmittner, John ;
Preston, Kenzie L. .
DRUG AND ALCOHOL DEPENDENCE, 2013, 130 (1-3) :77-84